However, there were no significant differences in clinicopathologic factors (age, sex, multifocality, pT stage, extrathyroid extension, and lymph node metastasis) except for tumor size, HT, and BRAF mutation between WLPTC and classic PTC. The gene discussed is BRAF; the disease is metastatic malignant neoplasm in the lymph nodes.